Dexcom (DXCM) Interest Coverage Ratio Growth (1y) (2011 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -6.18% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 66.99% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 32.53% |
| Mar 31, 2023 | 14.29% |
| Dec 31, 2022 | 20,800.00% |
| Sep 30, 2022 | 24.68% |
| Jun 30, 2022 | -22.14% |
| Mar 31, 2022 | -8.07% |
| Dec 31, 2021 | 105.20% |
| Sep 30, 2021 | 566.85% |
| Jun 30, 2021 | 530.01% |
| Mar 31, 2021 | 347.61% |
| Dec 31, 2020 | -136.97% |
| Sep 30, 2020 | 3.99% |
| Jun 30, 2020 | 6,362.32% |
| Mar 31, 2020 | 325.76% |
| Dec 31, 2019 | 133.05% |
| Sep 30, 2019 | 30.74% |
| Jun 30, 2019 | 94.78% |
| Mar 31, 2019 | 84.89% |
| Dec 31, 2018 | -886.20% |
| Sep 30, 2018 | 2,653.06% |
| Jun 30, 2018 | 76.73% |
| Mar 31, 2018 | 92.08% |
| Dec 31, 2017 | 112.56% |
| Sep 30, 2017 | 99.88% |
| Jun 30, 2017 | 97.82% |
| Mar 31, 2017 | 57.92% |
| Sep 30, 2016 | 78.18% |
| Jun 30, 2016 | -458.33% |
| Mar 31, 2016 | -202.36% |
| Sep 30, 2015 | -1,596.00% |
| Jun 30, 2015 | -24.14% |
| Mar 31, 2015 | -3.25% |
| Dec 31, 2014 | 204.35% |
| Sep 30, 2014 | 13.79% |
| Jun 30, 2014 | 41.41% |
| Mar 31, 2014 | -12.84% |
| Dec 31, 2013 | 81.53% |
| Dec 31, 2012 | -103.39% |
| Dec 31, 2011 | 394.46% |
| Sep 30, 2011 | -4,382.87% |
| Jun 30, 2011 | -4,206.10% |